Avoiding globalisation of the prescription opioid epidemic

The Lancet

Volumn 390, Issue 10093, 2017, Pages 437-439

  Humphreys, Keith ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; FENTANYL; HYDROCODONE; METHADONE; NALOXONE; OPIATE; OXYCODONE; OXYMORPHONE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; CHRONIC PAIN; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG OVERDOSE; EPIDEMIC; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HIGH INCOME COUNTRY; HUMAN; MEDICAL EDUCATION; NOTE; OPIATE ADDICTION; PAIN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; CLINICAL PRACTICE; GLOBAL HEALTH; INTERNATIONAL COOPERATION; PRESCRIPTION DRUG MISUSE; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ANALGESICS, OPIOID; DRUG INDUSTRY; GLOBAL HEALTH; HUMANS; INTERNATIONALITY; OPIOID-RELATED DISORDERS; PRACTICE PATTERNS, PHYSICIANS'; PRESCRIPTION DRUG MISUSE; UNITED STATES;

EID: 85025816773     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31918-9     Document Type: Note

References (22)

1. Clark, K, Deutch, TE, Kaptur, M, et al. Letter from Members of US Congress to WHO Director-General Margaret Chan. http://katherineclark.house.gov/_cache/files/a577bd3c-29ec-4bb9-bdba-1ca71c784113/mundipharma-letter-signatures.pdf, May 3, 2017 (accessed July 14, 2017).
2. Rudd, RA, Seth, P, David, F, Scholl, L, Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep 65 (2016), 1445–1452.
3. National Institute on Drug Abuse. Overdose death rates. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates, 2017 (accessed July 5, 2017).
4. US Centers for Disease Control and Prevention. Prescription opioid overdose data. https://www.cdc.gov/drugoverdose/data/overdose.html, 2016 (accessed July 5, 2017).
5. Quinones, S, Dreamland: the true tale of America's opiate epidemic, 2015, Bloomsbury Press, New York.
6. Lembke, A, Humphreys, K, Newmark, J, Weighing the risk and benefits of chronic opioid therapy. Am Fam Physician 93 (2016), 982–990.
7. United Nations International Narcotics Control Board. Narcotic drugs: estimated world requirements for 2017; statistics for 2015, 2016, United Nations International Narcotics Control Board, Vienna.
8. Fischer, B, Rehm, J, Revisiting the “paradigm shift” in opioid use: developments and implications 10 years later. Drug Alc Rev, 2017 published online March 23. http://dx.doi.org/10.1111/dar.12539.
9. Lembke, A, Drug dealer, MD: how doctors were duped, patients got hooked, and why it's so hard to stop, 2016, Johns Hopkins University Press, Baltimore, MD.
10. Robbins, R, Drug makers now spend $5 billion a year on advertising. Here's what that buys. Stat News, March 9, 2016 https://www.statnews.com/2016/03/09/drug-industry-advertising/ (accessed July 14, 2017).
11. Whyte, LE, Mulvihill, G, Wieder, B, Politics of pain: drugmakers fought state opioid limits amid crisis, Dec 15, 2016, Center for Public Integrity, Associated Press https://www.publicintegrity.org/2016/09/18/20200/politics-pain-drugmakers-fought-state-opioid-limits-amid-crisis (accessed July 14, 2017).
12. Ostrowksi, J, Thinking about drug legalization, 1989, Cato Institute, Washington, DC.
13. Lopez, G, I used to support legalizing all drugs. Then the opioid epidemic happened. Vox, April 20, 2017 https://www.vox.com/policy-and-politics/2017/4/20/15328384/opioid-epidemic-drug-legalization (accessed July 14, 2017).
14. Balko, R, The new panic over prescription painkillers. Huffington Post, April 9, 2012 http://www.huffingtonpost.com/radley-balko/us-painkillers-abuse_b_1263565.html (accessed July 14, 2017).
15. Meier, B, In guilty plea, Oxycontin maker to pay $600 million. The New York Times, May 10, 2007 http://www.nytimes.com/2007/05/10/business/11drug-web.html (accessed July 14, 2017).
16. US District Court for the Western District of Virginia. Case decision Case No. 1:07CR00029. http://www.vawd.uscourts.gov/OPINIONS/JONES/107CR00029.PDF, July 23, 2007 (accessed July 14, 2017).
17. Zeller, S, Clark takes on Purdue's marketing; says pharmaceutical company's “greed and recklessness” spawned opioid crisis. Commonwealth, July 11, 2017 https://commonwealthmagazine.org/drug-addiction/clark-takes-on-purdues-opioid-marketing/ (accessed July 18, 2017).
18. Ryan, H, Girion, L, Glover, S, OxyContin goes global—“We're only just getting started”. Los Angeles Times, Dec 18, 2016 http://www.latimes.com/projects/la-me-oxycontin-part3/ (accessed July 14, 2017).
19. Lamas, D, Rosenbaum, L, Painful inequities—palliative care in developing countries. New Engl J Med 366 (2012), 199–201.
20. US Food and Drug Administration. FDA requests removal of Opana ER for risks related to abuse. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm562401.htm, June 8, 2017 (accessed July 14, 2017).
21. Humphreys, K, An overdose rescue drug goes mainstream. Health Aff 34 (2015), 1624–1627.
22. Guy, G, Zhang, K, Bohm, MK, et al. Vital signs: changes in opioid prescribing in the United States, 2006–2015. MMWR Morb Mortal Wkly Rep 66 (2017), 697–704.